Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection

Launched by IMPERIAL COLLEGE LONDON · Mar 21, 2019

Keywords

ClinConnect Summary

This clinical trial is investigating a way to reduce the risk of brain injuries during a specific heart procedure called TEVAR, which is used to treat certain blood vessel problems. Many patients undergoing this procedure experience silent brain injuries or cognitive issues, which can significantly affect their quality of life. The trial will compare two methods of preparing the stent-grafts used in TEVAR—using carbon dioxide versus saline—to see which one better protects the brain during the procedure.

To participate in this trial, you need to be between the ages of 65 and 74 and suitable for the TEVAR procedure. It's important that you can give your consent to join the study. If you have a pacemaker, are pregnant, or are under 18, you would not be eligible. If you decide to take part, you will help researchers understand which method of preparing the stent-grafts might lead to better outcomes for patients undergoing TEVAR. Your involvement could contribute to improvements in treatment for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All participants suitable for TEVAR with capacity to consent
• Exclusion Criteria:
• • Participants who lack capacity to consent
• • Contraindications to MRI such as pacemaker
• • Pregnant participants
• • Participants who do not wish to participate
• • Participants \<18yrs